|
Endovasc is targeting its patented technologies
and drug products initially to certain segments of the cardiovascular
disease (CVD) market, including peripheral arterial disease and coronary heart disease (coronary
artery and ischemic heart disease).
Click on the links to the left for more information
and depictions on Coronary Artery Disease (CAD), and
Peripheral Artery Disease (PAD). |